2,4-Dichloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine

The primary applications of 2,4-dichloro-5-iodo-7H-pyrrolo[2,3-D]pyrimidine lie in medicinal chemistry as an intermediate for synthesizing pharmaceutical compounds. Its derivatives have been explored for:

• Anticancer Agents: Investigations into its potential as part of drug candidates targeting cancer pathways.
• Neurological Disorders: As mentioned previously, it shows promise in developing treatments for neurodegenerative diseases like Parkinson's disease.

Additionally, its unique structural features make it a candidate for further exploration in drug design and development.

Research indicates that 2,4-dichloro-5-iodo-7H-pyrrolo[2,3-D]pyrimidine exhibits notable biological activity, particularly as an inhibitor of specific enzymes involved in cellular signaling pathways. It has been studied for its potential role as a therapeutic agent against neurodegenerative diseases by targeting leucine-rich repeat kinase 2 (LRRK2), which is implicated in Parkinson's disease. The compound's ability to inhibit cytochrome P450 enzymes also suggests potential interactions that could affect drug metabolism and efficacy.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.